医疗设备制造商Revvity Inc.今日股价盘中大涨6%,引发了市场的广泛关注。这主要是由于公司公布的最新业绩超出分析师预期,以及推出新的股票回购计划等利好因素所致。
根据公司财报显示,尽管Revvity下调了2024财年收入预期,但其调整后每股收益预期却从4.70-4.80美元上调至4.83-4.87美元。与此同时,该公司第三季度的营收和利润均超出分析师预期。其强劲的诊断设备需求、有利的利润率和较低税率是推动业绩超预期的主要动力。
此外,Revvity董事会还批准了一项为期两年、总额为10亿美元的新股票回购计划,这显示了公司对自身发展前景的信心。这一利好消息也对公司股价产生了积极影响。总的来看,公司超预期的业绩表现以及新股票回购计划等利好因素,使得投资者对Revvity的长期增长前景更加乐观,从而推动了股价的大幅上涨。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.